Biden has been under pressure from progressive Democrats in Congress as well as health care groups to support the waiver for vaccine patents at the World Trade Organization, which backers say would help lower-income countries have access to the vaccine recipe so that they can increase production. The White House has for weeks declined to articulate a position, but Psaki provided more detail on Tuesday into the considerations the administration is weighing. ADVERTISEMENT "Our focus is on maximizing production and supply for the world at the lowest possible cost, and there are a lot of different ways to do that," she said.